To remember
- Focal treatment with MRI-guided focused ultrasound is safe and effective in some patients with grade 2 or 3 prostate cancer.
Why is this important?
- A comparative phase III trial is needed to determine whether a tissue-sparing approach can delay or eliminate the need for long-term radical whole-gland therapy in patients with intermediate-risk prostate cancer .
